Literature DB >> 8203126

Antibody response to Brucella melitensis outer membrane antigens in naturally infected and Rev1 vaccinated sheep.

M S Zygmunt1, H S Debbarh, A Cloeckaert, G Dubray.   

Abstract

Sera from Brucella infected and B. melitensis Rev1 vaccinated sheep were analysed by immunoblotting using the cell envelope fraction (CEF) of B. melitensis B115. The CEF of B. melitensis B115 was analysed using a bank of monoclonal antibodies. The fraction consisted mainly of S-LPS like molecules, R-LPS and outer membrane proteins (OMPs) of molecular masses of 10, 16.5, 19, 25-27, 31-34, 36-38, 73 and 89 kDa. Immunoblot analysis indicates that the antibody response in infected sheep was mainly directed against the major OMPs of 25-27, 31-34, 36-38 kDa, against 55 to 62, 70-73 and 89 to 94 kDa proteins associated with the CEF and, against S-LPS like molecules. Some infected sheep reacted with antigens of molecular mass lower than 20 kDa. Sera from vaccinated sheep reacted only with OMPs of 36-38, 60, 70-73 and 89 kDa. The major 25-27 and 31-34 kDa OMPs and proteins below 20 kDa were only detected by the sera of infected sheep. These differences may be due to the persistence of the field infection also reflected by the fact that antibody response against O-polysaccharide (O-PS), as measured by enzyme-linked immunosorbent assay (ELISA), was more intense in infected sheep than in vaccinated ones. These results also indicate that these OMPs could be useful to differentiate B. melitensis infection from B. melitensis Rev.1 vaccination in sheep.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8203126     DOI: 10.1016/0378-1135(94)90084-1

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  9 in total

1.  Cloning, nucleotide sequence, and expression of the Brucella melitensis sucB gene coding for an immunogenic dihydrolipoamide succinyltransferase homologous protein.

Authors:  M S Zygmunt; M A Díaz; A P Teixeira-Gomes; A Cloeckaert
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

2.  Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection.

Authors:  Juliana Cassataro; Silvia M Estein; Karina A Pasquevich; Carlos A Velikovsky; Silvia de la Barrera; Raúl Bowden; Carlos A Fossati; Guillermo H Giambartolomei
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

3.  Use of recombinant BP26 protein in serological diagnosis of Brucella melitensis infection in sheep.

Authors:  A Cloeckaert; S Baucheron; N Vizcaino; M S Zygmunt
Journal:  Clin Diagn Lab Immunol       Date:  2001-07

4.  Enzyme-linked immunosorbent assay with partially purified cytosoluble 28-kilodalton protein for serological differentiation between Brucella melitensis-infected and B. melitensis Rev.1-vaccinated sheep.

Authors:  H Salih-Alj Debbarh; A Cloeckaert; G Bézard; G Dubray; M S Zygmunt
Journal:  Clin Diagn Lab Immunol       Date:  1996-05

5.  Performance of competitive and indirect enzyme-linked immunosorbent assays, gel immunoprecipitation with native hapten polysaccharide, and standard serological tests in diagnosis of sheep brucellosis.

Authors:  C M Marín; E Moreno; I Moriyón; R Díaz; J M Blasco
Journal:  Clin Diagn Lab Immunol       Date:  1999-03

6.  Molecular characterization, occurrence, and immunogenicity in infected sheep and cattle of two minor outer membrane proteins of Brucella abortus.

Authors:  A Tibor; E Saman; P de Wergifosse; A Cloeckaert; J N Limet; J J Letesson
Journal:  Infect Immun       Date:  1996-01       Impact factor: 3.441

7.  Brucella melitensis cell envelope protein and lipopolysaccharide epitopes involved in humoral immune responses of naturally and experimentally infected sheep.

Authors:  M S Zygmunt; A Cloeckaert; G Dubray
Journal:  J Clin Microbiol       Date:  1994-10       Impact factor: 5.948

8.  Immunogenicity evaluation of plasmids encoding Brucella melitensis Omp25 and Omp31 antigens in BALB/c mice.

Authors:  Moslem Shojaei; Mojtaba Tahmoorespur; Mahdi Soltani; Mohammad Hadi Sekhavati
Journal:  Iran J Basic Med Sci       Date:  2018-09       Impact factor: 2.699

9.  Evaluation in mice of Brucella ovis attenuated mutants for use as live vaccines against B. ovis infection.

Authors:  Pilar Sancho; Carmen Tejedor; Rebeca S Sidhu-Muñoz; Luis Fernández-Lago; Nieves Vizcaíno
Journal:  Vet Res       Date:  2014-06-04       Impact factor: 3.683

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.